AVERY WILLIAMSON: Open Payments
NPI 1821548140 · WILLIAMSPORT, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,982 in 119 payments from 18 companies in 2025. Trend: 2023 $1,487 · 2024 $1,310 · 2025 $1,982
Food & beverage: $1,982
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $473 |
| Novo Nordisk Inc | 18 | $315 |
| Lilly USA, LLC | 14 | $241 |
| AstraZeneca Pharmaceuticals LP | 7 | $167 |
| PFIZER INC. | 13 | $161 |
| Phathom Pharmaceuticals, Inc. | 8 | $117 |
| Dexcom, Inc. | 6 | $107 |
| Amgen Inc. | 6 | $92 |
| Exact Sciences Corporation | 3 | $70 |
| GlaxoSmithKline, LLC. | 3 | $55 |
Products named: VRAYLAR, Ozempic, QULIPTA, JARDIANCE, VOQUEZNA, Dexcom G6 Transmitter, Wegovy, BREZTRI.
Industry payments across PA — which companies pay providers there.
